[Exhibition Info] CureApp to Exhibit at 'SusHi Tech Tokyo 2026', One of Asia's Largest Global Innovation Conferences
CureApp, Inc. announced its participation in 'SusHi Tech Tokyo 2026' from April 27 to 29, 2026. The company will showcase its medically evidence-based 'therapeutic apps' for smoking cessation, hypertension, and alcohol reduction, allowing visitors to experience the UI/UX firsthand.
📋 Article Processing Timeline
- 📰 Published: April 23, 2026 at 19:00
- 🔍 Collected: April 23, 2026 at 10:31
- 🤖 AI Analyzed: April 23, 2026 at 11:07 (35 min after Collected)
CureApp, Inc. (Headquarters: Chuo-ku, Tokyo; CEO: Kota Satake; hereinafter 'the Company') is pleased to announce its exhibition at 'SusHi Tech Tokyo 2026,' a venue for generating innovations and new actions that lead to solving global issues, to be held for three days from Monday, April 27 to Wednesday (holiday), April 29, 2026.
■ Background and Purpose of the Exhibition
As a pioneer in 'therapeutic apps' that treat diseases based on medical evidence, we have achieved everything from regulatory approval to insurance coverage and sales in areas such as smoking cessation, hypertension, and alcohol reduction.
We are exhibiting at 'SusHi Tech Tokyo 2026' to raise broad awareness of the current state and future potential of digital therapeutics among domestic and international municipalities, companies, medical professionals, and visitors interested in next-generation technology. Furthermore, we aim to pioneer new business partnerships and build a global network.
■ Exhibition Details: Experience the 'Feel' of Digital Therapeutics
At our booth, we will display the following therapeutic apps currently being utilized in medical settings:
- Smoking Cessation Treatment Support App for Nicotine Addiction
- Hypertension Treatment Support App for Hypertension
- Alcohol Reduction Treatment Support App for Alcohol Addiction
Visitors can actually pick up and experience the UI/UX of these 'therapeutic apps,' which are normally provided through medical institutions, using our demo devices. We will directly explain the mechanism of how our algorithms encourage behavioral changes in patients.
We will also have exhibits for our corporate businesses, 'ascure Smoking Cessation' and 'ascure Dr. Hypertension Treatment,' as well as the digital therapeutics social implementation platform 'DTx-BASE'.
* The exhibited items are demo devices and cannot be used for medical practices.
■ Exhibition Overview
Item / Details
Event Name: SusHi Tech Tokyo 2026
Dates:
Monday, April 27 and Tuesday, April 28, 2026, 9:00 AM - 6:30 PM
Wednesday (holiday), April 29, 2026, 10:00 AM - 6:00 PM (Registration opens 9:30 AM)
Venue: Tokyo Big Sight West Halls 1, 2, 3, 4, etc. (3-11-1 Ariake, Koto-ku, Tokyo)
Exhibition Category: SusHi Tech Global Area
Booth Location: 4th Floor, West Hall 4, 297
Official Website: https://sushitech-startup.metro.tokyo.lg.jp/
◆ About CureApp, Inc.
Founded by two physicians in 2014. A medical device manufacturer that researches, develops, manufactures, and sells 'therapeutic apps' whose therapeutic effects are proven in clinical trials and are prescribed to patients by doctors in clinical settings.
In 2020, as a program medical device for disease treatment operating on smartphones, the nicotine addiction treatment app achieved Japan's first* regulatory approval and insurance coverage, and was also the world's first* in the smoking cessation treatment area. Subsequently, it received regulatory approval and insurance coverage for therapeutic apps in hypertension and alcohol reduction treatments, which are now sold to medical institutions. Additionally, we are progressing with the development of therapeutic apps for multiple diseases such as NASH, cancer, chronic heart failure, and chronic lower back pain.
Furthermore, we operate the 'ascure Mobile Health Program,' a health promotion service for corporations, which has been introduced as a smoking cessation measure by numerous health insurance societies and companies. We have also started offering 'ascure Dr. Hypertension Treatment'.
* Internal research / Research date: December 2020 / Research scope: Japanese therapeutic apps and global therapeutic apps for nicotine addiction that have received manufacturing and sales approval and insurance coverage.
◆ Looking for friends for the Hypertension Information LINE 'Dapan'!
We will also announce upcoming campaigns supporting 'Salt Reduction Day' on the Hypertension Information LINE 'Dapan'. Please be sure to register.
Register for the Hypertension Information LINE 'Dapan' here.
CureApp, Inc. Company Profile
CEO: Kota Satake
Headquarters: 4F Kodenmacho YS Building, 12-5 Nihonbashi Kodenmacho, Chuo-ku, Tokyo
Business: Development of program medical devices, mobile health-related services business
URL: https://cureapp.co.jp/